Ralf Kuriyel - 30 Aug 2021 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Senior VP, R&D
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
30 Aug 2021
Net transactions value
-$1,128,802
Form type
4
Filing time
02 Sep 2021, 06:54:15 UTC
Previous filing
14 Jun 2021
Next filing
15 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Sale $1,128,802 -4,001 -19% $282.13 17,354 30 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 $282.13 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.10 to $282.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.